Absci Corp (ABSI)

Currency in USD
3.335
-0.105(-3.05%)
Closed·
3.360+0.025(+0.75%)
·
ABSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.2503.510
52 wk Range
2.0106.330
Key Statistics
Prev. Close
3.44
Open
3.51
Day's Range
3.25-3.51
52 wk Range
2.01-6.33
Volume
7.61M
Average Volume (3m)
4.67M
1-Year Change
3.57%
Book Value / Share
1.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABSI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.046
Upside
+141.25%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Absci Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Absci Corp Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Absci Corp Earnings Call Summary for Q2/2025

  • Q2 2025 revenue of $600,000 missed expectations by 56.83%, with EPS at -$0.24 vs -$0.21 forecast
  • R&D expenses increased to $20.5 million from $15.3 million YoY, reflecting continued focus on innovation
  • Company extended cash runway into 2028 through recent capital raises, with $117.5 million in cash as of June 30
  • Management anticipates signing at least one major pharma partnership in 2025, with interim results expected for key programs
  • Despite earnings miss, stock rose 4.39% in after-hours trading, suggesting investor optimism about long-term prospects
Last Updated: 08/13/2025, 05:34 AM
Read Full Transcript

Compare ABSI to Peers and Sector

Metrics to compare
ABSI
Peers
Sector
Relationship
P/E Ratio
−4.4x−4.1x−0.6x
PEG Ratio
−1.11−0.050.00
Price/Book
2.4x2.3x2.6x
Price / LTM Sales
178.1x165.8x3.3x
Upside (Analyst Target)
169.9%66.5%40.0%
Fair Value Upside
Unlock−1.2%3.2%Unlock

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.046
(+141.25% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Hold4.32+29.54%5.80DowngradeJan 08, 2026
H.C. Wainwright
Buy8.00+139.88%7.00MaintainDec 17, 2025
Jones Trading
Buy9.00+169.87%8.00MaintainNov 28, 2025
Morgan Stanley
Buy5.80+73.91%5.89MaintainNov 17, 2025
Needham
Buy7.00+109.90%8.00MaintainNov 13, 2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.20 / -0.20
Revenue / Forecast
380.00K / 1.40M
EPS Revisions
Last 90 days

ABSI Income Statement

People Also Watch

13.690
ONDS
-2.28%
84.850
RKLB
+2.13%
3.790
RR
-3.56%
49.45
IONQ
-1.98%

FAQ

What Is the Absci (ABSI) Stock Price Today?

The Absci stock price today is 3.335

What Stock Exchange Does Absci Trade On?

Absci is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Absci?

The stock symbol for Absci is "ABSI."

What Is the Absci Market Cap?

As of today, Absci market cap is 501.49M.

What Is Absci's Earnings Per Share (TTM)?

The Absci EPS (TTM) is -0.90.

When Is the Next Absci Earnings Date?

Absci will release its next earnings report on Mar 23, 2026.

From a Technical Analysis Perspective, Is ABSI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Absci Stock Split?

Absci has split 0 times.

How Many Employees Does Absci Have?

Absci has 157 employees.

What is the current trading status of Absci (ABSI)?

As of Jan 10, 2026, Absci (ABSI) is trading at a price of 3.335, with a previous close of 3.440. The stock has fluctuated within a day range of 3.250 to 3.510, while its 52-week range spans from 2.010 to 6.330.

What Is Absci (ABSI) Price Target According to Analysts?

The average 12-month price target for Absci is USD8.04571, with a high estimate of USD10 and a low estimate of USD4.32. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +141.25% Upside potential.

What Is the ABSI Premarket Price?

ABSI's last pre-market stock price is 3.500. The pre-market share volume is 179,880.000, and the stock has decreased by 0.060, or 1.740%.

What Is the ABSI After Hours Price?

ABSI's last after hours stock price is 3.360, the stock has decreased by 0.025, or 0.750%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.